Hybrid robot-assisted training for upper limb recovery after stroke
The Study Firstly Proposes a Hybrid Robot-assisted Training Program, Which Combines Two Types of Robotic Systems, to Enhance the Effectiveness of Robot-assisted Training and Provide a New Approach for Motor Training of Upper Limb in Stroke Patients
This study is testing whether a new type of robot-assisted training can help stroke survivors improve their arm movement and everyday activities better than traditional rehab methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 25 Years to 75 Years |
| Sex | All |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Taoyuan) |
| Trial ID | NCT05226988 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of hybrid robot-assisted training, which combines exoskeleton and end-effector devices, on stroke patients' motor performance and daily functioning. Participants will be randomly assigned to receive either hybrid training, exoskeleton training, end-effector training, or conventional rehabilitation over six weeks, with three sessions per week. The study aims to assess both immediate and long-term outcomes, including quality of life and self-efficacy, in individuals with chronic upper limb dysfunction following a stroke.
Who should consider this trial
Good fit: Ideal candidates are stroke survivors with unilateral paresis who have had their stroke for more than three months and can provide informed consent.
Not a fit: Patients with other neurological diseases or severe cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve motor function and quality of life for stroke survivors.
How similar studies have performed: Previous studies have shown mixed results regarding the effectiveness of robot-assisted training, making this hybrid approach a novel exploration in the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stroke more than 3 months. * Modified Ashworth Scale proximal part ≤ 3, Modified Ashworth Scale distal part ≤ 2, and no serious muscle spasms. * The myoelectric signal can be detected to activate the instrument * Unilateral paresis (FMA score\<60) * No serious cognitive impairment (i.e., Mini Mental State Exam score \> 24) * Can provide informed consent Exclusion Criteria: * Other neurological disease * Complete sense of body defect * Inability to understand instructions * current participation in any other research * Botulinum Toxin injection within 3 months
Where this trial is running
Taoyuan
- Chang Gung Memotial Hospital — Taoyuan, Taiwan (Recruiting)
Study contacts
- Study coordinator: Ching-yi Wu, ScD
- Email: cywu@mail.cgu.edu.tw
- Phone: #886-3-2118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.